BACKGROUND: The relative contribution and interaction of risk factors for multiple sclerosis (MS) have not been evaluated. OBJECTIVES: To determine whether vitamin D status is associated with antibody levels to common viruses in pediatric-onset MS or clinically isolated syndrome (CIS) patients and controls. METHODS: We assessed whether vitamin D status was associated with viral antibody levels to Epstein-Barr virus, cytomegalovirus (CMV), and herpes simplex virus (HSV)-1 or -2 in subjects who demonstrated evidence of remote infection with these viruses and whether these associations differed depending on disease status. RESULTS: In 140 subjects, vitamin D status was weakly associated with antibody levels to CMV but not to the other viruses. However, there were some interactions between vitamin D status and disease state. Among those with vitamin D sufficiency (≥30 ng/ml), MS/CIS patients had higher antibody levels to Epstein-Barr nuclear antigen-1 than controls. Vitamin D sufficiency was associated with higher CMV antibody levels in MS/CIS subjects but lower CMV antibody levels in controls. Higher vitamin D levels appeared to be associated with higher titers to HSV-2 in MS/CIS patients but not controls. CONCLUSIONS: Vitamin D status may be differentially associated with antibody levels to common childhood viruses among seropositive subjects.
BACKGROUND: The relative contribution and interaction of risk factors for multiple sclerosis (MS) have not been evaluated. OBJECTIVES: To determine whether vitamin D status is associated with antibody levels to common viruses in pediatric-onset MS or clinically isolated syndrome (CIS) patients and controls. METHODS: We assessed whether vitamin D status was associated with viral antibody levels to Epstein-Barr virus, cytomegalovirus (CMV), and herpes simplex virus (HSV)-1 or -2 in subjects who demonstrated evidence of remote infection with these viruses and whether these associations differed depending on disease status. RESULTS: In 140 subjects, vitamin D status was weakly associated with antibody levels to CMV but not to the other viruses. However, there were some interactions between vitamin D status and disease state. Among those with vitamin D sufficiency (≥30 ng/ml), MS/CIS patients had higher antibody levels to Epstein-Barr nuclear antigen-1 than controls. Vitamin D sufficiency was associated with higher CMV antibody levels in MS/CIS subjects but lower CMV antibody levels in controls. Higher vitamin D levels appeared to be associated with higher titers to HSV-2 in MS/CIS patients but not controls. CONCLUSIONS:Vitamin D status may be differentially associated with antibody levels to common childhood viruses among seropositive subjects.
Authors: F Di Pauli; M Reindl; R Ehling; F Schautzer; C Gneiss; A Lutterotti; Ej O'Reilly; Kl Munger; F Deisenhammer; A Ascherio; T Berger Journal: Mult Scler Date: 2008-07-16 Impact factor: 6.312
Authors: Lisa F Barcellos; Stephen Sawcer; Patricia P Ramsay; Sergio E Baranzini; Glenys Thomson; Farren Briggs; Bruce C A Cree; Ann B Begovich; Pablo Villoslada; Xavier Montalban; Antonio Uccelli; Giovanni Savettieri; Robin R Lincoln; Carolyn DeLoa; Jonathan L Haines; Margaret A Pericak-Vance; Alastair Compston; Stephen L Hauser; Jorge R Oksenberg Journal: Hum Mol Genet Date: 2006-08-11 Impact factor: 6.150
Authors: Lynn I Levin; Kassandra L Munger; Mark V Rubertone; Charles A Peck; Evelyne T Lennette; Donna Spiegelman; Alberto Ascherio Journal: JAMA Date: 2005-05-25 Impact factor: 56.272
Authors: James R Sabetta; Paolo DePetrillo; Ralph J Cipriani; Joanne Smardin; Lillian A Burns; Marie L Landry Journal: PLoS One Date: 2010-06-14 Impact factor: 3.240
Authors: R A Farrell; D Antony; G R Wall; D A Clark; L Fisniku; J Swanton; Z Khaleeli; K Schmierer; D H Miller; G Giovannoni Journal: Neurology Date: 2009-05-20 Impact factor: 9.910
Authors: Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight Journal: PLoS Genet Date: 2009-02-06 Impact factor: 5.917
Authors: Jennifer Graves; Siri Grandhe; Kelley Weinfurtner; Lauren Krupp; Anita Belman; Tanuja Chitnis; Jayne Ness; Bianca Weinstock-Guttman; Mark Gorman; Marc Patterson; Moses Rodriguez; Tim Lotze; Gregory Aaen; Ellen M Mowry; John W Rose; Timothy Simmons; T Charles Casper; Judith James; Emmanuelle Waubant Journal: Neurology Date: 2014-10-22 Impact factor: 9.910